Hyperlipidemia and glomerular sclerosis: an alternative viewpoint.

Sharon Anderson, A. J. King, B. M. Brenner

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Clinical and experimental observations suggest an association between hypercholesterolemia and progressive glomerular injury. In the main, most investigators have assumed that hypercholesterolemia induces an atherosclerotic process in the renal microvasculature analogous to that well recognized in larger vessels. The evidence for this line of reasoning is well described in other papers in this symposium. It is our belief that hypercholesterolemia may also lead to glomerular injury by hemodynamic mechanisms. In support of this latter view, diet-induced hypercholesterolemia often raises blood pressure in experimental animals and markedly impairs endothelial cell-dependent vascular relaxation in vitro. A high cholesterol diet also increases renal vascular resistance and contributes to glomerular capillary hypertension, a hemodynamic maladaptation known to cause glomerular sclerosis. In addition, hypercholesterolemia results in hyperviscosity, a rheologic abnormality leading to increased efferent arteriolar resistance and glomerular hypertension. The similar glomerular hemodynamic responses to two hyperviscosity states, elevated hematocrit and hypercholesterolemia, implicate efferent arteriolar hyperviscosity as a potential mechanism of injury common to hyperviscosity states. It therefore seems likely that as in atherosclerosis, multiple risk factors act synergistically to initiate glomerular structural injury. Specifically, we suggest that hypercholesterolemia and glomerular hypertension act synergistically to initiate structural injury. Although modification of either risk factor may limit injury, it seems likely that therapy targeted to each of multiple risk factors may afford superior protection.

Original languageEnglish (US)
JournalAmerican Journal of Medicine
Volume87
Issue number5 N
StatePublished - Nov 1989
Externally publishedYes

Fingerprint

Sclerosis
Hypercholesterolemia
Hyperlipidemias
Wounds and Injuries
Hemodynamics
Hypertension
Diet
Kidney
Microvessels
Hematocrit
Vascular Resistance
Atherosclerosis
Endothelial Cells
Cholesterol
Research Personnel
Blood Pressure

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Hyperlipidemia and glomerular sclerosis : an alternative viewpoint. / Anderson, Sharon; King, A. J.; Brenner, B. M.

In: American Journal of Medicine, Vol. 87, No. 5 N, 11.1989.

Research output: Contribution to journalArticle

@article{26b024c9520a405b980d966bdfb040c2,
title = "Hyperlipidemia and glomerular sclerosis: an alternative viewpoint.",
abstract = "Clinical and experimental observations suggest an association between hypercholesterolemia and progressive glomerular injury. In the main, most investigators have assumed that hypercholesterolemia induces an atherosclerotic process in the renal microvasculature analogous to that well recognized in larger vessels. The evidence for this line of reasoning is well described in other papers in this symposium. It is our belief that hypercholesterolemia may also lead to glomerular injury by hemodynamic mechanisms. In support of this latter view, diet-induced hypercholesterolemia often raises blood pressure in experimental animals and markedly impairs endothelial cell-dependent vascular relaxation in vitro. A high cholesterol diet also increases renal vascular resistance and contributes to glomerular capillary hypertension, a hemodynamic maladaptation known to cause glomerular sclerosis. In addition, hypercholesterolemia results in hyperviscosity, a rheologic abnormality leading to increased efferent arteriolar resistance and glomerular hypertension. The similar glomerular hemodynamic responses to two hyperviscosity states, elevated hematocrit and hypercholesterolemia, implicate efferent arteriolar hyperviscosity as a potential mechanism of injury common to hyperviscosity states. It therefore seems likely that as in atherosclerosis, multiple risk factors act synergistically to initiate glomerular structural injury. Specifically, we suggest that hypercholesterolemia and glomerular hypertension act synergistically to initiate structural injury. Although modification of either risk factor may limit injury, it seems likely that therapy targeted to each of multiple risk factors may afford superior protection.",
author = "Sharon Anderson and King, {A. J.} and Brenner, {B. M.}",
year = "1989",
month = "11",
language = "English (US)",
volume = "87",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5 N",

}

TY - JOUR

T1 - Hyperlipidemia and glomerular sclerosis

T2 - an alternative viewpoint.

AU - Anderson, Sharon

AU - King, A. J.

AU - Brenner, B. M.

PY - 1989/11

Y1 - 1989/11

N2 - Clinical and experimental observations suggest an association between hypercholesterolemia and progressive glomerular injury. In the main, most investigators have assumed that hypercholesterolemia induces an atherosclerotic process in the renal microvasculature analogous to that well recognized in larger vessels. The evidence for this line of reasoning is well described in other papers in this symposium. It is our belief that hypercholesterolemia may also lead to glomerular injury by hemodynamic mechanisms. In support of this latter view, diet-induced hypercholesterolemia often raises blood pressure in experimental animals and markedly impairs endothelial cell-dependent vascular relaxation in vitro. A high cholesterol diet also increases renal vascular resistance and contributes to glomerular capillary hypertension, a hemodynamic maladaptation known to cause glomerular sclerosis. In addition, hypercholesterolemia results in hyperviscosity, a rheologic abnormality leading to increased efferent arteriolar resistance and glomerular hypertension. The similar glomerular hemodynamic responses to two hyperviscosity states, elevated hematocrit and hypercholesterolemia, implicate efferent arteriolar hyperviscosity as a potential mechanism of injury common to hyperviscosity states. It therefore seems likely that as in atherosclerosis, multiple risk factors act synergistically to initiate glomerular structural injury. Specifically, we suggest that hypercholesterolemia and glomerular hypertension act synergistically to initiate structural injury. Although modification of either risk factor may limit injury, it seems likely that therapy targeted to each of multiple risk factors may afford superior protection.

AB - Clinical and experimental observations suggest an association between hypercholesterolemia and progressive glomerular injury. In the main, most investigators have assumed that hypercholesterolemia induces an atherosclerotic process in the renal microvasculature analogous to that well recognized in larger vessels. The evidence for this line of reasoning is well described in other papers in this symposium. It is our belief that hypercholesterolemia may also lead to glomerular injury by hemodynamic mechanisms. In support of this latter view, diet-induced hypercholesterolemia often raises blood pressure in experimental animals and markedly impairs endothelial cell-dependent vascular relaxation in vitro. A high cholesterol diet also increases renal vascular resistance and contributes to glomerular capillary hypertension, a hemodynamic maladaptation known to cause glomerular sclerosis. In addition, hypercholesterolemia results in hyperviscosity, a rheologic abnormality leading to increased efferent arteriolar resistance and glomerular hypertension. The similar glomerular hemodynamic responses to two hyperviscosity states, elevated hematocrit and hypercholesterolemia, implicate efferent arteriolar hyperviscosity as a potential mechanism of injury common to hyperviscosity states. It therefore seems likely that as in atherosclerosis, multiple risk factors act synergistically to initiate glomerular structural injury. Specifically, we suggest that hypercholesterolemia and glomerular hypertension act synergistically to initiate structural injury. Although modification of either risk factor may limit injury, it seems likely that therapy targeted to each of multiple risk factors may afford superior protection.

UR - http://www.scopus.com/inward/record.url?scp=0024769379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024769379&partnerID=8YFLogxK

M3 - Article

C2 - 2486544

AN - SCOPUS:0024769379

VL - 87

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 5 N

ER -